Trials / Sponsors / TVAX Biomedical
TVAX Biomedical
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme Glioblastoma Multiforme of Brain | Phase 2 / Phase 3 | 2023-09-15 |
| Completed | Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma Grade IV Glioma, Grade IV Astrocytoma, Glioblastoma Multiforme | Phase 2 | 2011-06-01 |
| Completed | Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma Glioma, High Grade Astrocytoma, Glioblastoma Multiforme | Phase 1 / Phase 2 | 2010-04-01 |
| No Longer Available | TVI-Brain-1 in Expanded Access Patient Recurrent Glioblastoma | — | — |